Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Melanoma

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    July 2022
  1. ZHANG YJ, Xie R, Jiang J, Zhai L, et al
    5AzadC suppresses melanoma progression by inhibiting GAS5 hypermethylation.
    Oncol Rep. 2022;48.
    PubMed     Abstract available

    February 2022
  2. KO H, Ahn HJ, Kim YI
    Methylation and mutation of the inhibinalpha gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    November 2021
  3. HAN X, Jia Y, Chen X, Sun C, et al
    lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR4245p/LATS1 axis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    October 2021
  4. CHEN Y, Zhang Z, Luo C, Chen Z, et al
    [Retracted] MicroRNA18b inhibits the growth of malignant melanoma via inhibition of HIF1alphamediated glycolysis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    September 2021
  5. KODAMA S, Podyma-Inoue KAlpha, Uchihashi T, Kurioka K, et al
    Progression of melanoma is suppressed by targeting all transforming growth factorbeta isoforms with an Fc chimeric receptor.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    August 2021
  6. STACHYRA-STRAWA P, Ciesielka M, Janiszewski M, Grzybowska-Szatkowska L, et al
    The role of immunotherapy and moleculartargeted therapy in the treatment of melanoma (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    April 2021
  7. URANOWSKA K, Kalic T, Valtsanidis V, Kitzwogerer M, et al
    Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

    April 2020
  8. LIU X, Li Z, Li M, Chai J, et al
    Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF.
    Oncol Rep. 2020 Apr 15. doi: 10.3892/or.2020.7582.
    PubMed     Abstract available

    January 2020
  9. KRAJEWSKI A, Gagat M, Zuryn A, Halas-Wisniewska M, et al
    Cyclin F is involved in response to cisplatin treatment in melanoma cell lines.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7465.
    PubMed     Abstract available

  10. MIERZEJEWSKA J, Szczygiel A, Anger-Gora N, Rossowska J, et al
    DeOacylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity.
    Oncol Rep. 2020;43:270-281.
    PubMed     Abstract available

    October 2019
  11. RAHMAN MM, Lai YC, Husna AA, Chen HW, et al
    Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma.
    Oncol Rep. 2019 Oct 25. doi: 10.3892/or.2019.7391.
    PubMed     Abstract available

  12. LICARETE E, Rauca VF, Luput L, Patras L, et al
    The prednisolone phosphateinduced suppression of the angiogenic function of tumorassociated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7346.
    PubMed     Abstract available

    September 2019
  13. HOU X, Pang Y, Li X, Yang C, et al
    Coreshell type thermonanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells.
    Oncol Rep. 2019 Sep 20. doi: 10.3892/or.2019.7329.
    PubMed     Abstract available

  14. KUCERA J, Strnadova K, Dvorankova B, Lacina L, et al
    Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.
    Oncol Rep. 2019 Sep 17. doi: 10.3892/or.2019.7319.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.